




Searching News Database: Hana Biosciences
HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
HSMN NewsFeed - 4 Oct 2011
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
HSMN NewsFeed - 16 Dec 2009
Hana Biosciences Appoints Howard Furst, M.D., M.B.A., to Board of Directors
Hana Biosciences Appoints Howard Furst, M.D., M.B.A., to Board of Directors
HSMN NewsFeed - 12 Jan 2009
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed - 24 Apr 2008
Hana Biosciences Appoints Anne E. Hagey, M.D., Vice President and Chief Medical Officer
Hana Biosciences Appoints Anne E. Hagey, M.D., Vice President and Chief Medical Officer
HSMN NewsFeed - 30 Aug 2007
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
HSMN NewsFeed - 22 May 2007
Hana Biosciences Announces Vice President Appointment in Regulatory Affairs and Quality Assurance
Hana Biosciences Announces Vice President Appointment in Regulatory Affairs and Quality Assurance
HSMN NewsFeed - 23 Mar 2007
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
HSMN NewsFeed - 26 Feb 2007
INEX Provides Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
INEX Provides Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 20 Feb 2007
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
HSMN NewsFeed - 30 Aug 2006
FDA Accepts for Review NDA Filing for Zensana(TM) (Ondansetron HCI) Oral Spray
FDA Accepts for Review NDA Filing for Zensana(TM) (Ondansetron HCI) Oral Spray
HSMN NewsFeed - 5 Jul 2006
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
HSMN NewsFeed - 8 May 2006
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
HSMN NewsFeed - 17 Mar 2006
Hana Biosciences to License Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Hana Biosciences to License Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
HSMN NewsFeed - 17 Mar 2006
Inex Pharmaceuticals Licenses Three Targeted Chemotherapy Products to Hana Biosciences
Inex Pharmaceuticals Licenses Three Targeted Chemotherapy Products to Hana Biosciences
Additional items found! 12

Members Archive contains
12 additional stories matching:
Hana Biosciences
(Password required)
Hana Biosciences
(Password required)